The drug named 'molnupiravir' developed by Merck and Ridgeback has been authorised for those who have mild to moderate covid-19 symptoms.
from The Financial Express https://ift.tt/3BSzJtp
Monday, 8 November 2021
Two new oral drugs approved for the Covid treatment; details here
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment